Compare eBay Inc (EBAY) vs Organon & Co. Common Stock (OGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs Organon & Co. Common Stock — how do they compare? eBay Inc trades at $117.9 (market cap $52.01B), while Organon & Co. Common Stock trades at $13.58 (market cap $3.62B). The key difference: eBay Inc is far larger — about 14.4× Organon & Co. Common Stock's market cap, and eBay Inc pays the higher dividend (1.06%). Which is the better fit depends on your goals — on Pluang, investors hold eBay Inc for 134 Days and Organon & Co. Common Stock for 0 Days on average.
| EBAY | OGN | |
|---|---|---|
Market Cap | $52.01B | $3.62B |
Volume | 3,194,736 | 2,892,999 |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $13.81 |
52-Week Low | $79.41 | $5.70 |
Typical Hold Time | 134 Days | 0 Days |
Enterprise Value | $55.83B | $11.04B |
Dividend Yield | 1.06% | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $116.41, up 1.54% today, near its consensus price target of $117.89. The stock shows strong technical momentum with bullish moving averages and recent earnings beats. Revenue grew to $11.10B in 2025, with robust profitability margins including a net income margin of 18.57%. Recent news highlights strategic focus on collectibles and live commerce, while facing scrutiny over banned product listings.
Outlook remains cautiously optimistic with analyst consensus leaning buy (49% buy ratings). Key opportunities include projected revenue growth to $12.0B in 2026 and expanding margins. Risks involve competitive pressures from Amazon's multi-platform tools, insider selling by executives, and regulatory challenges as seen in recent gender-test kit probe.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →
